Friday, November 18, 2016
Print Current Day:
![]() |
|
SESSION 71 SCHEDULE | |
Friday
SESSION 71:
UPDATED OR NEW CAROTID ASSESSMENT TECHNIQUES, TECHNOLOGY OR CONCEPTS
Moderators:Ali F. AbuRahma, MD / Glenn Jacobowitz, MD
|
|
x | |
ASSESSMENT OF CAROTID PLAQUE RISK | |
6:40 AM - 6:45 AM | Progress In Non-Invasive Prediction Of High Risk Asymptomatic Carotid Plaques Using Bio-Optical Imaging To Detect Macrophage Infiltration And MMPs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Slides in PDF | |
6:46 AM - 6:51 AM | Use Of Web-Based Platforms And Features Of The Arterial Wall For Risk Stratification Of Asymptomatic Carotid Plaques: Can These Features And Risks Be Modified By Statins |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
6:52 AM - 6:57 AM | Can We Identify The Small Percentage Of ACS Patients Who May Benefit From CEA Or CAS: What Is That Percentage |
Presenter(s):Henrik Sillesen, MD, DMSc | |
6:58 AM - 7:03 AM | Assessment Of Carotid Plaque Embolic Risk With 3D MRI: Correlation With TCD And Diffusion Weighted Brain MRI |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
7:04 AM - 7:09 AM | How Plaque Morphological Studies Can Resolve The Controversy Regarding Treatment Of Patients With Asymptomatic Carotid Stenosis (ACS) And Which Patients Should Undergo Invasive Treatment |
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Carotid Interventions Should Not Be Based On Consensus Duplex Velocity Criteria: More Stringent Criteria Can Reduce Unnecessary Procedures And Show The Value Of Interventions In CREST 2 |
Presenter(s):Mark F. Fillinger, MD | |
View Slides in PDF | |
7:16 AM - 7:21 AM | Pitfalls In The Sole Use Of Duplex Scans In Decision Making For Treatment Of Carotid Lesions |
Presenter(s):Glenn M. LaMuraglia, MD / Richard P. Cambria, MD | |
View Slides in PDF | |
7:22 AM - 7:27 AM | What Is The Significance Of Asymptomatic Emboli During Carotid Procedures: They Cannot Be Good |
Presenter(s):Mark H. Wholey, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | How Can Asymptomatic Carotid Stenosis Progression Be Predicted And How Can It Help Clinical Decision Making |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
7:34 AM - 7:39 AM | Current Status Of Methods To Reliably And Non-Invasively Detect Asymptomatic Plaques At A High Risk Of Causing A Stroke |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
7:40 AM - 7:45 AM | Panel Discussion |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
Friday
SESSION 72:
SPINAL CORD ISCHEMIA (SCI) WITH TAAA AND THORACIC ANEURYSM (TAA) REPAIRS; ITS PATHOGENESIS, PREVENTION AND TREATMENT
Moderators:Richard P. Cambria, MD / Matthew J. Eagleton, MD
|
|
x | |
7:46 AM - 7:51 AM | Critical Review Of Spinal Cord Protection From SCI In TAAAs – Open And Endo: Current Concepts And Future Prospects |
Presenter(s):Christian D. Etz, MD, PhD | |
View Slides in PDF | |
7:52 AM - 7:57 AM | The 4-Territory Hypothesis For Risk Stratification In SCI And How It Can Help In Prophylaxis And Treatment Of SCI With Thoracic Aortic Procedures |
Presenter(s):Martin Czerny, MD | |
View Slides in PDF | |
7:58 AM - 8:03 AM | New Concepts In Paraplegia After TEVAR: What Role Does Spinal Cord Edema Play, What Causes It And How Can It Be Prevented |
Presenter(s):Hamdy Awad, MD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | Mechanisms Of SCI In Open TAAA Repair And F/BEVAR: How Do They Differ And How Should Prevention And Management Differ |
Presenter(s):Charles W. Acher, MD | |
View Slides in PDF | |
8:10 AM - 8:15 AM | Update On Prevention And Consequences Of SCI During Open And Endo TAAA And TAA Repairs: What Is Different Between Open And Endo Procedures And Treatment |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Motor Evoked Potentials (MEPs) As An Indicator For Selective Staging Of B/FEVARs And TAAA Repairs: Technique And Results |
Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD | |
View Slides in PDF | |
8:22 AM - 8:27 AM | Relevance Of MEPs In Endovascular TAAA Repairs And Strategies To Decrease Paraplegia |
Presenter(s):Piotr M. Kasprzak, MD | |
View Slides in PDF | |
8:28 AM - 8:33 AM | Value Of Intrathecal Papaverine In Decreasing SCI And Paraplegia With Complex TAA And TAAA Repairs |
Presenter(s):Eric E. Roselli, MD / Lars G. Svensson, MD, PhD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Technique And Limits Of Spinal Drainage With TAA And TAAA Repairs: How To Prevent Spinal Drain Complications |
Presenter(s):Mark A. Farber, MD / Anthony L. Estrera, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | The Real Truth About The Incidence And Consequences Of SCI After Open And Endo TAAA Repair: Methods Of Prevention |
Presenter(s):Nicholas J.W. Cheshire, MD | |
View Slides in PDF | |
8:46 AM - 8:51 AM | Remote Ischemic Pre-Conditioning: What Is It And Can It Protect Against SCI |
Presenter(s):Thomas L. Forbes, MD | |
View Slides in PDF | |
8:52 AM - 9:00 AM | Panel Discussion |
9:00 AM - 9:12 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 72 | |
SESSION 73 SCHEDULE | |
x | |
9:12 AM - 9:17 AM | Emergency CEA For A Stroke In Evolution: When Is It Indicated And How Should It Be Performed |
Presenter(s):Afshin Assadian, MD / Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
TOPICS RELATED TO COGNITIVE CHANGES | |
9:18 AM - 9:23 AM | Size Of Embolic Particles Released During CAS Matters And Correlates With Neuro-Cognitive Deterioration After The Procedure |
Presenter(s):Wei Zhou, MD | |
View Slides in PDF | |
9:24 AM - 9:29 AM | Effect Of Carotid Interventions On Cognition: Does CAS/CEA Improve Or Worsen Cognitive Function: Cognitive Tests Should Be An Outcome Measures For CAS And CEA |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
9:30 AM - 9:35 AM | Prospective Comparison Of Neuropsychologic Outcomes After CEA And Protected CAS (TCAR): Despite An Increase In Emboli And DW MRI Lesions With CAS, No Differences Were Noted On Testing |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
View Slides in PDF | |
9:36 AM - 9:41 AM | Comparison Of Left Carotid Subclavian Bypass And Transposition: Pros And Cons Of Each For Primary Subclavian Disease And With TEVAR |
Presenter(s):Mark K. Eskandari, MD | |
View Slides in PDF | |
9:42 AM - 9:47 AM | Proper Technique For Subclavian To Carotid Artery Transposition |
Presenter(s):Mark D. Morasch, MD, FACS, RPVI / Ramon Berguer, MD, PhD | |
View Slides in PDF | |
9:48 AM - 9:53 AM | Fate Of Non-Operated False Aneurysms After Acute Carotid Dissections: How Should They Be Managed |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
9:54 AM - 9:59 AM | Management Of Carotid Patch Infection With And Without False Aneurysms: Proving Infection Can Be Hard – How To Do It |
Presenter(s):Patrick A. Stone, MD / Ali F. AbuRahma, MD | |
View Slides in PDF | |
10:00 AM - 10:05 AM | Systematic Review Of Stroke And Death Rates After CAS And CEA In 21 Contemporary Big Registries: These Adverse Event Rates Are Higher Than Expected From RCTs: In Symptomatic And Asymptomatic Patients |
Presenter(s):Ross Naylor, MD, FRCS / Kosmas I. Paraskevas, MD | |
View Slides in PDF | |
10:06 AM - 10:11 AM | Use Of Covered Stents (Stent-Grafts) For Carotid Artery Injuries, Patch And Tumor False Aneurysms And Blowouts: How To Use Them Safely And Long-Term Results |
Presenter(s):Michael B. Silva, Jr., MD | |
View Slides in PDF | |
10:12 AM - 10:20 AM | Panel Discussion |
END OF SESSION 73 | |
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
MORE HOT CAROTID RELATED TOPICS; FLAWED GUIDELINES; IMPACT OF MEDICAL THERAPY, CAS AND CEA; STROKE PREDICTION
Moderators:Mark A. Adelman, MD / Kim J. Hodgson, MD
|
|
x | |
10:20 AM - 10:25 AM | What Is Wrong With Current Carotid Guidelines: How Important Is Bias: What Would An Evidence-Based Carotid Guideline Look Like |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
10:26 AM - 10:31 AM | How Low Do Statins Have To Go To Drive LDL-C To Produce Carotid Plaque Regression And Improved Echogenicity; Value Of Ezetimibe In Getting There And Of 3D Ultrasound In Detecting Regression |
Presenter(s):J. David Spence, MD | |
View Slides in PDF | |
10:32 AM - 10:37 AM | Contralateral ICA Occlusion Is A Major Stroke/Death Risk Factor For CEA But Not For CAS: Single Center And A Meta-Analysis Show It |
Presenter(s):Gianluca Faggioli, MD / Andrea Stella, MD / Mauro Gargiulo, MD | |
View Slides in PDF | |
10:38 AM - 10:43 AM | New Developments In Transcranial Doppler (TCD) Testing: How It Can Help In Everyday Clinical Practice |
Presenter(s):Zsolt Garami, MD | |
View Slides in PDF | |
10:44 AM - 10:49 AM | Endovascular ICA Occlusion After Intracranial Thrombus Removal In Patients With Tandem (Intracranial And Extracranial Lesions) To Prevent Further Intracranial Embolization And Second Strokes: Advantages, Precautions And Limitations |
Presenter(s):Emmanuel M. Houdart, MD | |
View Slides in PDF | |
10:50 AM - 10:55 AM | Decrease In Mental Acuity, DW MRI Lesions And Cranial Nerve Injuries Should Be Outcome Measures (End Points) In Comparisons Of CAS And CEA |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
View Slides in PDF | |
10:56 AM - 11:01 AM | Impact Of Post-Procedural TIAs On Long-Term Survival After CAS And CEA: TIAs Are Not Innocuous |
Presenter(s):Andrea Stella, MD / Gianluca Faggioli, MD | |
View Slides in PDF | |
11:02 AM - 11:10 AM | Panel Discussion |
Moderator(s): Frank J. Veith, MD / Ross Naylor, MD, FRCS | |
11:10 AM - 11:15 AM | What Are Predictors Of Bad Outcomes After CAS; After CEA: They Are Not The Same |
Presenter(s):Kim J. Hodgson, MD | |
View Slides in PDF | |
11:16 AM - 11:21 AM | Anatomical And Technical Predictors Of Stroke And Death After CAS |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
11:22 AM - 11:27 AM | Mechanisms Of Procedural Strokes In The ICSS And ACST I Trials: What Are The Practice Implications And What Is The Value Of Troponins In Patients Undergoing CEA Or CAS |
Presenter(s):Gert J. de Borst, MD | |
View Slides in PDF | |
11:28 AM - 11:33 AM | Clinical And Procedural Variables That Modify The Risk Of Stroke, MI And Death After CEA And CAS In Symptomatic Carotid Stenosis Patients: What Can Be Done To Lower These Risks |
Presenter(s):Afshin Assadian, MD / Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
11:34 AM - 11:39 AM | What Is The Current Gold Standard Of Cerebral Protection With CAS |
Presenter(s):Giancarlo Biamino, MD, PhD | |
View Slides in PDF | |
11:40 AM - 11:45 AM | When Can A Mini-Incision (1.5 inches – 4 cm) CEA Be Performed With Or Without A Shunt: Tips And Tricks To Do It Safely |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
View Slides in PDF | |
11:46 AM - 11:51 AM | Diaphragm Of The ICA: An Underdiagnosed Cause Of Recurrent Stroke: How Can It Best Be Diagnosed And Treated |
Presenter(s):Emmanuel M. Houdart, MD | |
View Slides in PDF | |
11:52 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
MORE CAROTID DISEASE AND TREATMENT RELATED TOPICS AND CONTROVERSIES; TRANSCERVICAL CAS (TCAR) AND NEW MESH COVERED CAROTID STENTS
Moderators:Klaus D. Mathias, MD / Claudio J. Schonholz, MD
|
|
x | |
1:00 PM - 1:05 PM | Midterm Results Of The ROADSTER PIVOTAL Trial Of The Silk Road System For TransCarotid Artery Stent Revascularization (TCAR) In High Risk Patients With Carotid Stenosis |
Presenter(s):Mahmoud B. Malas, MD, MHS / Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | New Developments In The Silk Road System For TCAR: Details And Improvements In The Enroute System For CAS: How It Works And Achieves Flow Reversal Embolic Protection: Indications, Contraindications And Learning Curve Issues |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Early Results Of The ROADSTER 2 Post-Market Registry Of TCAR In Normal Risk And High Risk Patients With Carotid Stenosis |
Presenter(s):Vikram S. Kashyap, MD / Peter A. Schneider, MD | |
View Slides in PDF | |
MEGA DEBATE ON TIMING AFTER SYMPTOM ONSET | |
1:18 PM - 1:23 PM | DEBATE: Early CEA After Symptom Onset Is Beneficial To Patients: The Earlier The Better After Certain Requirements Are Met |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | DEBATE: Early CEA After Symptoms (TIA Or Small Stroke): Timing Is Everything: Within 48 Hours Is Bad: Within 3-14 Days Is Good: Why |
Presenter(s):Ian Loftus, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Early CEA (Within 48 Hours) After TIA Or Stroke: A Balanced View: What Are The Risks And Benefits: Early Brain Imaging And Carotid Duplex Can Help Select Patients For Safe, Early Intervention |
Presenter(s):Laura Capoccia, MD, PhD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Another Balanced View: When Is Early CEA After Symptom Onset In Patients With Carotid Stenosis Safe And Beneficial And When Is It Not |
Presenter(s):Martin Bjorck, MD, PhD | |
View Slides in PDF | |
NEW MESH COVERED CAROTID STENTS | |
1:42 PM - 1:47 PM | Comparison Of 3 Micromesh Covered Stents For CAS: Indications For Each And > 1-Year Clinical Results |
Presenter(s):Piotr Musialek, MD, DPhil / Max Amor, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | Impact Of TCAR And Micro-Mesh Stent Usage With The C-Guard Stent (Inspire MD) On CAS: Do They Decrease DW MRI Cerebral Embolic Lesions: Which Helps Most |
Presenter(s):Piotr Musialek, MD, DPhil / Mariusz Trystula, MD, PhD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | Dual Layer Micromesh Stents Decrease New Ischemic Brain Lesions After CAS: What Is The Functional Significance And Will These Micromesh Stents Have Downsides |
Presenter(s):Maria Antonella Ruffino, MD, EBIR | |
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
LATE BREAKING INFORMATION AND TRIAL STATUS RELATED TO CAROTID DISEASE AND ITS TREATMENT: CREST 2, ECST 2 AND ACST 2 STATUS AND ISSUES
Moderators:Enrico Ascher, MD / Richard P. Cambria, MD
|
|
x | |
CREST 2 RELATED TOPICS | |
2:06 PM - 2:11 PM | Where Do We Stand With CREST 2 And What Will It Tell Us |
Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Will CREST 2 Incorporate Recent Advances In CAS (Cervical Access, Reversal Of Flow And Mesh Covered Stents) And What Will It Tell Us |
Presenter(s):L. Nelson Hopkins, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | CREST 2 May Change Little Or Nothing In Carotid Treatment Practice: Why Is This So |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Why CREST 2 May Tell Us Very Little But Still Be Bad For Carotid Stenting (CAS) |
Presenter(s):Mark H. Wholey, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Barriers To Enrollment In CREST 2: How Can They Be Overcome |
Presenter(s):Mark Conrad, MD, MMSc | |
View Slides in PDF | |
2:36 PM - 2:41 PM | History Of Transcervical CAS And How To Do It With Standard Equipment |
Presenter(s):Enrique Criado, MD, FACS | |
View Slides in PDF | |
2:42 PM - 2:48 PM | Panel Discussion |
Moderator(s): L. Nelson Hopkins, MD / Max Amor, MD | |
2:48 PM - 2:53 PM | New Findings From CREST 1: Relationship Between Plaque Morphology And Post-Procedural Neurologic Events: Which Plaques Are High Risk For CAS But Not For CEA |
Presenter(s):Wesley S. Moore, MD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Update On The ECST 2 Trial: What Is It Telling Us Relevant To Carotid Lesion Treatment |
Presenter(s):Jonathan D. Beard, ChM, MEd, FRCS / Martin M. Brown, MD / Leo H. Bonati, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Update On The ACST 2 Trial Comparing CAS And CEA In Asymptomatic Patients: Lessons Learned To Date |
Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS | |
View Slides in PDF | |
3:06 PM - 3:11 PM | Current Optimal Management Of Radiation Carotid Stenosis: Risk Of CEA And CAS And Which Is The Best Treatment For Symptomatic And Asymptomatic Disease In This Setting |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
3:12 PM - 3:17 PM | International Variability In Carotid And AAA Treatment: Highlights From The International Consortium Of Vascular Registries |
Presenter(s):Jack L. Cronenwett, MD | |
View Slides in PDF | |
3:18 PM - 3:24 PM | Panel Discussion |
3:24 PM - 3:36 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
NEW CAROTID CONCEPTS AND UPDATES
Moderators:Ali F. AbuRahma, MD / Bruce A. Perler, MD, MBA
|
|
x | |
3:36 PM - 3:41 PM | Carotid Pseudo-Occlusions: How Are They Best Diagnosed And Treated: What Are The Results Of Treatment And No Treatment |
Presenter(s):Sonia Ronchey, MD, PhD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Spontaneous Recanalization Of An Occluded Internal Carotid Artery (ICA): What Is The Clinical Significance |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
View Slides in PDF | |
3:48 PM - 3:53 PM | Carotid Bypass With Gore Hybrid Graft As A Rescue Method For CEA Gone Bad During The Operation: Technique And 1-Year Results |
Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS | |
View Slides in PDF | |
3:54 PM - 3:59 PM | Contemporary Population-Based Outcomes For CAS And CEA: From The SVS Registry: How Do We Know The Data Are Accurate |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
View Slides in PDF | |
4:00 PM - 4:05 PM | Comparison Of Mesh Covered C-Guard Stent vs. Wallstent For CAS: DW MRI And Clinical Results Show Benefit Of Mesh Covered Stent |
Presenter(s):Laura Capoccia, MD, PhD | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Are There Clinical Advantages Of Micromesh Covered And Dual Layer Stent Designs Over Closed Cell Stents In CAS |
Presenter(s):Stefan Müller-Hülsbeck, MD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | DEBATE: CAS Has No Increased Cost Consequences Compared To CEA |
Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | DEBATE: Not So: CEA Costs Less Than CAS: Why The Discrepancy |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Carotid Webs Can Cause Strokes: How Should They Be Diagnosed And Treated: Should They Be Treated If Asymptomatic |
Presenter(s):Evan C. Lipsitz, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | Current Status Of Surgery For Carotid Body Tumors: What Is New With Techniques And Adjuncts |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
4:36 PM - 4:42 PM | Panel Discussion |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
NEW CONCEPTS AND UPDATES RELATED TO PERCUTANEOUS EVAR (PEVAR), WOUND CARE, SYMPATHECTOMY, MULTIPLE ANEURYSMS, ENDOVASCULAR NARROWING AND BRIDGING ANTICOAGULATION
Moderators:Peter F. Lawrence, MD / Jerry Goldstone, MD, FACS, FRCSEd
|
|
x | |
UPDATE ON PEVAR | |
4:42 PM - 4:47 PM | New Developments And Devices For PEVAR: What Is On The Horizon – Especially For Large Bore Sheaths |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
4:48 PM - 4:53 PM | Percutaneous EVAR (PEVAR) vs. Open Surgical Access For EVAR: A Single Center RCT And The Multicenter PIERO RCT: An Overview Of Cost Effectiveness And Complications Of Both Procedures |
Presenter(s):Afshin Assadian, MD / Clark J. Zeebregts, MD, PhD | |
View Slides in PDF | |
4:54 PM - 4:59 PM | How To Perform PEVAR: Tips And Tricks (Video Presentation) |
Presenter(s):Zoran Rancic, MD, PhD | |
View Slides in PDF | |
5:00 PM - 5:05 PM | Update On Fascial Suture Closure For PEVAR: Safety, Technical Tips And How It Saves Time And Money |
Presenter(s):Thomas Larzon, MD, PhD | |
View Slides in PDF | |
5:06 PM - 5:11 PM | Large Sheath Closure With The Proglide Device: Tips, Tricks And Economic Value |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
5:12 PM - 5:17 PM | Cost Implications Of PEVAR: How Can It Be Made Cost Effective |
Presenter(s):Maciej L. Dryjski , MD, PhD | |
View Slides in PDF | |
OTHER NEW CONCEPTS | |
5:18 PM - 5:23 PM | What’s New In Wound Care In PAD, The Diabetic Foot And Combined Arterial And Venous Ulcerations |
Presenter(s):Katherine A. Gallagher, MD | |
View Slides in PDF | |
5:24 PM - 5:29 PM | Renaissance For Chemical Sympathectomy In A Vascular Practice: Indications, Techniques And Results |
Presenter(s):Donald B. Reid, MD | |
View Slides in PDF | |
5:30 PM - 5:35 PM | Multifocal Synchronous Aorto-Iliac Femoro-Popliteal Aneurysms: Sequence And Strategies For Access And Treatment: Does It Depend On Aneurysm Size |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
5:36 PM - 5:41 PM | Onion Skin And Other Techniques For Decreasing, In A Controlled Manner, Excessive Flows Through Blood Vessels Or Stent-Grafts While Maintaining Patency |
Presenter(s):Jerry Matteo, MD | |
View Slides in PDF | |
5:42 PM - 5:47 PM | Best Current Bridging Treatment For Anticoagulated Patients Requiring Vascular Surgery |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
5:48 PM - 5:58 PM | Panel Discussion End of Program J |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
NEW DEVELOPMENTS IN THE TREATMENT OF ANEURYSMS AND OTHER DISEASES INVOLVING THE POPLITEAL ARTERY
Moderators:Eric L.G. Verhoeven, MD, PhD / Martin Bjorck, MD, PhD
|
|
x | |
POPLITEAL ANEURYSMS | |
6:40 AM - 6:45 AM | Why Do We Still Need Open Surgery For Some Popliteal Aneurysms: What Are The Indications – Relative And Absolute |
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS | |
View Slides in PDF | |
6:46 AM - 6:51 AM | Comparison Of Open And Endo Popliteal Aneurysms Repair In The Same Patients |
Presenter(s):Samy S. Nitecki, MD | |
View Slides in PDF | |
6:52 AM - 6:57 AM | DEBATE: Endovascular Repair Of Popliteal Aneurysms Is Less Risky Than Open Repair And Should Be The Procedure Of Choice: What Percent Of Patients Should Be Treated Endo |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS | |
View Slides in PDF | |
6:58 AM - 7:03 AM | DEBATE: Not So: Open Repair Is Better For Most Popliteal Aneurysm Patients: Endo Repair Is Sometimes A Failed Experiment |
Presenter(s):Martin Bjorck, MD, PhD | |
View Slides in PDF | |
7:04 AM - 7:09 AM | How Should Giant Popliteal Aneurysms Be Treated: Open vs. Endo And Tips And Tricks |
Presenter(s):Jacques Busquet, MD | |
View Slides in PDF | |
7:10 AM - 7:15 AM | Duplex Guided Endovascular Repair Of Popliteal Aneurysms: Why It Is A Better Way |
Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD / Anil P. Hingorani, MD | |
View Slides in PDF | |
POPLITEAL ENTRAPMENT SYNDROMES | |
7:16 AM - 7:21 AM | New Developments In And Present Status Of Diagnosis And Treatment For Popliteal Entrapment Syndromes |
Presenter(s):Niten Singh, MD | |
View Slides in PDF | |
7:22 AM - 7:27 AM | When Should Patients With Popliteal Arterial Compression Be Treated By PTA Plus Surgical Decompression: Long-Term (10-Year) Results Show It Is Sometimes The Better Treatment |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | Why Flexed Knee Angiography Should Always Be Performed To Control All Popliteal Interventions Or Procedures |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
7:34 AM - 7:40 AM | Panel Discussion |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
INFECTED ARTERIES AND ARTERIAL GRAFTS AND THEIR TREATMENT: INFECTED EVARs; MYCOTIC AAAs; INFECTED AORTIC/ARTERIAL PROSTHETIC GRAFTS; TREATMENT OF AORTO-ESOPHAGEAL FISTULA
Moderators:Glenn Jacobowitz, MD / Gary Giangola, MD
|
|
x | |
MANAGEMENT OF INFECTED EVARS | |
7:40 AM - 7:45 AM | DEBATE: Update On Treatment Of Infected Aortic Endografts: Open Surgical Graft Excision Is Always Indicated |
Presenter(s):Kamphol Laohapensang, MD | |
View Slides in PDF | |
7:46 AM - 7:51 AM | DEBATE: Not So: Semi-Conservative Treatment Without Graft Excision And With Drainage And Antibiotic Irrigation Of AAA Sac Can Be Effective Treatment: Longer-Term Results Prove It |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
7:52 AM - 7:57 AM | Treatment Of Infected Abdominal Endografts: Radical vs. Conservative: Late Survival Results With Each Treatment – From A Multicenter Study |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
TREATMENT OF MYCOTIC AAAS | |
7:58 AM - 8:03 AM | Long-Term Outcome Of EVAR Treatment For Mycotic AAAs: What Risk Factors Impact On Late Survival |
Presenter(s):I-Hui Wu, MD, PhD | |
View Slides in PDF | |
8:04 AM - 8:09 AM | When Aortic Infections And Mycotic AAAs Are Treated By EVAR, Early Success Does Not Equal Late Success: The Infection Returns: What To Do About It |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
8:10 AM - 8:15 AM | For Mycotic AAAs What Is The Value Of Endovascular Techniques And EVAR: When Are They Temporary Solutions And When Durable Treatment |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
8:16 AM - 8:21 AM | Value Of Vein Graft Covered Stent For Treatment Of Mycotic AAAs: Technique And Results |
Presenter(s):Klaus M. Overbeck, MD, MPhil | |
View Slides in PDF | |
8:22 AM - 8:28 AM | Panel Discussion |
TREATMENT OF AORTIC GRAFT INFECTION | |
Moderator(s): Thomas C. Bower, MD / Keith D. Calligaro, MD | |
8:28 AM - 8:33 AM | Intra-Abdominal Extra-Anatomic Reconstruction For Suprarenal Aortic And Graft Infection: Techniques And Results |
Presenter(s):Manju Kalra, MBBS / Thomas C. Bower, MD | |
View Slides in PDF | |
8:34 AM - 8:39 AM | Current Status Of Treatment For Aortic Graft Infection: When Should Cryopreserved Allografts Be Used And When Not: How Well Do They Work Long-Term |
Presenter(s):Peter F. Lawrence, MD | |
View Slides in PDF | |
8:40 AM - 8:45 AM | New Developments In The Treatment Of Prosthetic Aortic Graft Infection Facilitate In Situ Repair: Negative Pressure Wound Therapy And Bovine Pericardium Vascular Grafts: Techniques And Results |
Presenter(s):Max Zegelman, MD | |
View Slides in PDF | |
8:46 AM - 8:51 AM | Good Early Results Of Negative Pressure Wound Non-Excisional Treatment For Prosthetic Graft Infection Are Durable: It Is A Game Changer: Techniques And Long-Term Results |
Presenter(s):Dieter O. Mayer, MD / Barbara Hasse, MD / Mario L. Lachat, MD / Zoran Rancic, MD, PhD | |
View Slides in PDF | |
8:52 AM - 8:57 AM | Treatment Of Unilateral Limb Infection Of An Aortobifemoral Prosthetic Graft: Single Limb Excision Is Effective In ~50% Of Cases: When Should It Be Attempted: Diagnosis And Techniques |
Presenter(s):Gregory L. Moneta, MD | |
View Slides in PDF | |
THORACIC GRAFT INFECTIONS | |
8:58 AM - 9:03 AM | How Best To Treat Infectious Complications Of Open And Endo Thoracic Aortic Repairs |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
9:04 AM - 9:09 AM | Treatment Of Post-TEVAR Aorto-Esophageal Fistula: Only Radical Surgery Can Be Effective: Techniques And Sequence Of Treatment |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
9:10 AM - 9:16 AM | Panel Discussion |
9:16 AM - 9:24 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
ADVANCES IN IMAGING, GUIDANCE AND HYBRID SUITES/ORs
Moderators:Gustavo S. Oderich, MD FACS / Martin Malina, MD, PhD
|
|
x | |
9:24 AM - 9:29 AM | What Vascular Surgeons Need To Know About Peripheral CT Angiography (CTA) And MR Angiography (MRA) To Make Them Most Valuable For Vascular Decision Making |
Presenter(s):Michael H. Wholey, MD, MBA | |
View Slides in PDF | |
9:30 AM - 9:35 AM | 3D Live Interactive Holography For Vascular Interventions: Advantages And Limitations |
Presenter(s):Elchanan Bruckheimer, MBBS | |
View Slides in PDF | |
ADVANCED RADIOGRAPHIC IMAGING: FUSION AND DYNA-CT | |
9:36 AM - 9:41 AM | Principles Of Fusion Techniques And Dyna-CT: Advantages And Limitations During EVAR And TEVAR |
Presenter(s):Dittmar Boeckler, MD | |
View Slides in PDF | |
9:42 AM - 9:47 AM | DEBATE: Hybrid Rooms With Fixed Fluoroscopy Units, Fusion And Dyna-CT Are Essential For Complex EVAR Procedures (F/BEVAR) |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
9:48 AM - 9:53 AM | DEBATE: Not So: Results With Complex EVARs (F/BEVAR) Performed With C-Arm Mobile Imaging Fluoroscopy Units Are As Good As Those Done With Fixed Equipment In A Hybrid Suite |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Slides in PDF | |
9:54 AM - 9:59 AM | Advantages Of The Ziehm Vision RFD Hybrid Mobile Motorized C-Arm And Stille ImagiQ2 Floating Table: How Do They Compare With Fixed Hybrid Equipment For Complex Aortic Procedures |
Presenter(s):Peter C.J. Goverde, MD | |
View Slides in PDF | |
10:00 AM - 10:05 AM | 3D Fusion Is Possible With Any Digital C-Arm Mobile Fluoroscope Using The Cydar Software System: How It Works And Can Simplify And Improve Fusion Techniques |
Presenter(s):Tom Carrell, MD, MChir / Cynthia K. Shortell, MD | |
View Slides in PDF | |
10:06 AM - 10:12 AM | Panel Discussion |
WHAT IS ON THE HORIZON WITH IMAGING | |
Moderator(s): Frans L. Moll, MD, PhD / Daniel G. Clair, MD | |
10:12 AM - 10:17 AM | New Developments In Imaging That Are On The Horizon And That Will Change Our Management Of Most Complex Vascular Interventional Treatments |
Presenter(s):Lieven F. Maene, MD | |
View Slides in PDF | |
10:18 AM - 10:23 AM | The Future Of Vascular Imaging And Guidance: Where Are They Going |
Presenter(s):Alan B. Lumsden, MD, FACS | |
View Slides in PDF | |
10:24 AM - 10:29 AM | DEBATE: Ultrasound Imaging And Guidance Are The Best Method To Control Retrograde Distal Access Procedures And Crossing CTOs: Tips And Tricks |
Presenter(s):Constantino Pena, MD / Jihad A. Mustapha, MD | |
View Slides in PDF | |
10:30 AM - 10:35 AM | DEBATE: Not So: Fluoroscopy And Angiography Are The Best Way To Control Distal Puncture Procedures And Lesion Crossing: Technical Tips And Tricks |
Presenter(s):Andrej Schmidt, MD | |
View Slides in PDF | |
10:36 AM - 10:41 AM | Advanced Imaging Tools (The Vessel Assist System From GE) Can Improve 3D Imaging And Fusion And Facilitate Lower Extremity And CAS Procedures |
Presenter(s):Koen Deloose, MD | |
View Slides in PDF | |
10:42 AM - 10:47 AM | Why IVUS Use Should Become Standard Of Care In An Endovascular Practice: In What Procedures Is It A Must |
Presenter(s):Donald B. Reid, MD | |
View Slides in PDF | |
10:48 AM - 10:53 AM | Update On Strategies To Reduce Contrast Induced Nephropathy: What Works And What Doesn’t |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
10:54 AM - 11:00 AM | Panel Discussion |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs) AND CARDIAC EVALUATION
Moderators:Larry H. Hollier, MD / Gregory L. Moneta, MD
|
|
x | |
ADVANCES IN NEUROGENIC TOS | |
11:00 AM - 11:05 AM | New Objective Outcomes Reporting For Neurogenic TOS |
Presenter(s):Karl A. Illig, MD | |
View Slides in PDF | |
11:06 AM - 11:11 AM | Neurogenic TOS In Competitive Athletes: Is It Real: How Is It Best Diagnosed And Managed |
Presenter(s):Michael J. Singh, MD | |
View Slides in PDF | |
11:12 AM - 11:17 AM | Diagnosis And Optimal Treatment For Neurogenic TOS: The Supraclavicular Approach For First Rib Resection Is Best: How To Do It Well |
Presenter(s):Robert W. Thompson, MD | |
View Slides in PDF | |
11:18 AM - 11:23 AM | What Comprises TOS Specific Physical Therapy And How Often Is It Effective In Neurogenic TOS |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
11:24 AM - 11:29 AM | Robot Assisted Thoroscopic Minimally Invasive Treatment Of TOS Including First Rib Resection: How Is It Done (Video), Advantages And Limitations |
Presenter(s):Hans M.E. Coveliers, MD, PhD, MBA | |
View Slides in PDF | |
TREATMENT OF VENOUS TOS | |
11:30 AM - 11:35 AM | Optimal Way To Diagnose And Treat Venous TOS With Axillary-Subclavian Vein Thrombosis: Both The Supraclavicular And Infraclavicular Approaches Are Needed For Vein Exposure And Reconstruction |
Presenter(s):Robert W. Thompson, MD | |
View Slides in PDF | |
11:36 AM - 11:41 AM | Tips And Tricks For Transaxillary First Rib Resection For Venous TOS: The Subclavian Vein Seldom If Ever Needs To Be Surgically Reconstructed |
Presenter(s):Benjamin M. Jackson, MD | |
View Slides in PDF | |
11:42 AM - 11:47 AM | Infraclavicular Approaches To Venous TOS: Technique, Advantages And Limitation: What Can Be Done If The Subclavian Vein Needs To Be Reconstructed Or Cleaned Out |
Presenter(s):Joseph J. Ricotta II, MD, MS | |
View Slides in PDF | |
PRE-OP CARDIAC EVALUATION | |
11:48 AM - 11:53 AM | Are Cardiology Evaluations Of Any Value Before Vascular Operations: What Is Of Value: Current State Of The Art |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
NEW OR UPDATED CONCEPTS AND TREATMENTS FOR VASCULAR TRAUMA AND TAKAYASU’S DISEASE; MEDICAL TOPICS AND TREATMENTS
Moderators:Michael B. Silva, Jr., MD / Joanelle Z. Lugo, MD
|
|
x | |
1:00 PM - 1:05 PM | How To Reduce Door-To-Reperfusion Time With Severe Arterial Trauma |
Presenter(s):Markus K. Furrer, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | New Developments In Endovascular Treatment And Balloon Occlusion For Major Arterial Trauma: What Is REBOA And Does Partial Aortic Balloon Occlusion Have Value |
Presenter(s):Tal M. Hörer, MD, PhD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA) For Trauma Or Ruptured AAA: Is There A Role For IVUS Guidance To Facilitate Placement By Non-Interventionalists |
Presenter(s):Donald L. Jacobs, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Update On An Improved Classification System, TEVAR Devices And Techniques For Blunt Thoracic Aortic Injury (BTAI) |
Presenter(s):Ali Azizzadeh, MD / Benjamin W. Starnes, MD | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Indications For Early Non-Operative Treatment With BTAI: It Is Safe And Lowers Mortality In Selected Patients: Indications For Early TEVAR |
Presenter(s):Robert S. Crawford, MD / Donald G. Harris, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Endovascular Treatment Of Traumatic Aortic Rupture In Children: What Devices Can Be Used For TEVAR |
Presenter(s):Gabriel Szendro, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Tips And Tricks For Recognizing And Treating Acute Popliteal Artery Injuries (Lacerations And Occlusions) After Orthopedic Knee Surgery: They Are Often Missed |
Presenter(s):Sohail Khan, MD | |
View Slides in PDF | |
TAKAYASU’S DISEASE | |
1:42 PM - 1:47 PM | Bypasses vs. Endovascular Treatments For Symptomatic Takayasu’s Arteritis: Pros And Cons Of Each |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
OTHER TOPICS | |
1:48 PM - 1:53 PM | Current Management Strategies For Ehlers Danlos Syndrome And Role Of Endografts In The Treatment Of Its Arterial Lesions |
Presenter(s):James H. Black, III, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | Preop Non-Invasive Fractional Flow Reserve (FFR) Evaluation Of Coronary Lesion Can Improve Care And Decrease Costs In Vascular Patients: Technique And Results |
Presenter(s):Tej M. Singh, MD, MBA | |
View Slides in PDF | |
2:00 PM - 2:08 PM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
NEW DEVELOPMENTS AND UPDATES REGARDING CCSVI IN MULTIPLE SCLEROSIS; USE OF DRUGS IN VASCULAR DISEASE PATIENTS AND WAYS TO PREDICT RISKS OF ADVERSE EVENTS
Moderators:Caron B. Rockman, MD / Russell H. Samson, MD, RVT, FACS
|
|
x | |
CCSVI | |
2:08 PM - 2:13 PM | Multicenter Blinded RCT To Determine Safety And Effectiveness (Quality Of Life) Of Venous PTA For Multiple Sclerosis (The BRAVE DREAMS Trial): Design And Progress: Will It Settle The Controversy |
Presenter(s):Paolo Zamboni, MD | |
View Slides in PDF | |
DRUG TREATMENT OF VASCULAR DISEASES | |
2:14 PM - 2:19 PM | How Can Statins And Other Medical Treatment Decrease The Amputation And Major Adverse Limb Event Rates After Revascularizations For CLI: What Are The Optimal Drugs And Dosages |
Presenter(s):Patrick A. Stone, MD / Aravinda Nanjundappa, MD | |
View Slides in PDF | |
2:20 PM - 2:25 PM | Optimal Use Of ACE Inhibitors, Cilostazol, And Statins In Patients Undergoing Open And Endovascular Procedures |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:26 PM - 2:31 PM | Update On When And How Should Beta Blockers Be Used In Low Risk And High Risk Vascular Patients Generally And When They Undergo Operations And Interventions: Dosage Is Key |
Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC | |
View Slides in PDF | |
2:32 PM - 2:37 PM | Improving Non-Coronary Stent Outcomes By Pharmacological Manipulations – 2C19 And Plavix: How Do They Do It |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Slides in PDF | |
2:38 PM - 2:43 PM | What Is New In Antiplatelet Treatment Of Vascular Patients: Which Drugs In Which Situation: New Drugs And What Does The EUCLID Trial Tell Us |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC / Caron B. Rockman, MD | |
View Slides in PDF | |
2:44 PM - 2:50 PM | Panel Discussion |
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Elliot L. Chaikof, MD, PhD | |
2:50 PM - 2:55 PM | Benefits Of Perioperative Statins In Improving Outcomes And Decreasing Adverse Events After AAA And Carotid Procedures – Endo And Open: Optimal Timing, Drug And Dosage |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
2:56 PM - 3:01 PM | Update On The Medical (Drug) Treatment Of AAA Disease: What Does Metformin Do: Does Any Drug Slow AAA Growth |
Presenter(s):Ronald L. Dalman, MD | |
View Slides in PDF | |
3:02 PM - 3:07 PM | Should Bivalirudin Replace Heparin In Non-Cardiac Interventions: Advantages And How To Use It |
Presenter(s):George H. Meier III, MD | |
View Slides in PDF | |
VALUE OF TESTS | |
3:08 PM - 3:13 PM | Biomarkers Can Predict Long-Term (~10 Years) Adverse Cardiovascular Events In Vascular Patients: Which Ones And How Can They Be Used |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Slides in PDF | |
3:14 PM - 3:19 PM | How To Identify Patients At Risk Of Cardiovascular Adverse Events After EVAR |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
3:20 PM - 3:26 PM | Panel Discussion |
3:26 PM - 3:36 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
NEW CONCEPTS AND TECHNIQUES TO DECREASE RADIATION EXPOSURE FOR ENDOVASCULAR SURGEONS/SPECIALISTS AND PATIENTS
Moderators:Barry T. Katzen, MD / Evan C. Lipsitz, MD
|
|
x | |
3:36 PM - 3:41 PM | Crucial Elements In Radiation Safety For Non-Radiology Interventionists: Advice From A Radiologist |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Comparison Of Radiation Dosage And Safety Between Mobile C-Arm Fluoroscopes And Fixed Hybrid Units |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
3:48 PM - 3:53 PM | What Part Of Interventional Physicians Are At Risk From Radiation And Is Protective Gear Really Protective: Light Weight Lead Aprons Are A Hoax |
Presenter(s):Lindsay Machan, MD | |
View Slides in PDF | |
3:54 PM - 3:59 PM | How To Minimize Radiation Exposure During Complex Endovascular AAA Repairs: Tips And Tricks |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
4:00 PM - 4:05 PM | New Processing Software And Other Techniques For Reducing Radiation Exposure During Complex Interventional Procedures |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
4:06 PM - 4:11 PM | How OCT (Optical Coherence Tomography) Imaging Can Control Crossing Of CTOs And Decrease Radiation Exposure: So Too Can Expanded Use Of Duplex And IVUS |
Presenter(s):Todd R. Vogel, MD, MPH | |
View Slides in PDF | |
4:12 PM - 4:17 PM | Worrisome Biologic And Dosimetric Effects Of Operator Radiation Exposure During Complex Interventional Procedures: How Can They Be Measured And Decreased |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
4:18 PM - 4:23 PM | Malignancies Occurring During CT Follow-Up Of EVAR: It Is A Real Risk And What To Do About It |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
4:24 PM - 4:32 PM | Panel Discussion |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
RECORDED LIVE CASES OF COMPLEX AORTIC ANEURYSM TREATMENT WITH ENDOVASCULAR TECHNIQUES
Moderators:Giovanni Torsello, MD / Gustavo S. Oderich, MD FACS
|
|
x | |
4:32 PM - 4:52 PM | Complex Cases From Münster |
Presenter(s):Giovanni Torsello, MD | |
View Slides in PDF | |
4:52 PM - 5:02 PM | Questions And Discussion |
5:03 PM - 5:23 PM | Complex Cases From The Mayo Clinic – Including Use Of A 3D Model With Pump Perfusion (Sande Stabile) For Planning And Simulation |
Presenter(s):Gustavo S. Oderich, MD FACS | |
View Slides in PDF | |
5:23 PM - 5:35 PM | Questions And Discussion End of Program K |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
VENOUS CROSS-SECTIONAL IMAGING TECHNIQUES, PELVIC VENOUS DISORDERS
|
|
x | |
6:58 AM - 6:59 AM | Introduction To Deep Veins |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
7:00 AM - 7:05 AM | Evaluation Of The Severity Of Venous Obstruction |
Presenter(s):Olivier Hartung, MD | |
View Slides in PDF | |
7:06 AM - 7:11 AM | Getting A Look At Inflow With Duplex Ultrasound Prior To Endovascular Reconstruction Of Post-Thrombotic Iliocaval Disease |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
7:12 AM - 7:17 AM | How To Measure Iliac Vein Stenosis |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
7:18 AM - 7:23 AM | Pertinent IVUS Anatomy |
Presenter(s):Paul J. Gagne, MD | |
View Slides in PDF | |
7:24 AM - 7:29 AM | Novel Imaging Techniques With MRI For Thrombus Aging |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | The Bull’s-Eye Sign And Other Iliocaval-Femoral Venographic Findings: A New Classification To Limit The Use Of Intravascular Ultrasound |
Presenter(s):Enrico Ascher, MD | |
View Slides in PDF | |
7:36 AM - 7:41 AM | A New Look At Venous Hemodynamics: Measuring Reflux And Venous Outflow Obstruction |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Slides in PDF | |
7:42 AM - 7:47 AM | MRV And Major Venous Interventions |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
7:48 AM - 7:53 AM | MRV And CTV In Imaging Of Pelvic And Abdominal Venous Compressive Syndromes: Which Is Better And Why |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
7:54 AM - 7:58 AM | Panel Discussion |
PELVIC VENOUS DISORDERS | |
7:59 AM - 8:04 AM | Reasons New Nomenclature Is Needed For Pelvic Venous Disorders |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
8:05 AM - 8:10 AM | Pelvic Venous Incompetence And Leg Varicosities: Start From Above Or Below |
Presenter(s):Melvin Rosenblatt, MD | |
View Slides in PDF | |
8:11 AM - 8:16 AM | Pelvic Varices Are Best Studied With Trans-Vaginal Duplex Ultrasound |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
8:17 AM - 8:22 AM | Venographic Technique To Identify Pelvic Anatomy And Escape Points |
Presenter(s):Mark H. Meissner, MD | |
View Slides in PDF | |
8:23 AM - 8:28 AM | Ovarian Vein Incompetence Or Renal Vein Compression |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
8:29 AM - 8:34 AM | Acute Or Chronic Ovarian Vein Thrombosis: What To Do |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
8:35 AM - 8:40 AM | DEBATE: Renal Vein Transposition (With Patch) Is The Ideal Treatment For Nutcracker Syndrome, Not Stenting |
Presenter(s):Olivier Hartung, MD | |
View Slides in PDF | |
8:41 AM - 8:46 AM | DEBATE: Gonadal Vein Transposition Is The Ideal Treatment For Nutcracker Syndrome |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
8:47 AM - 8:52 AM | DEBATE: Stenting Is The Ideal Treatment For Nutcracker Syndrome |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
8:53 AM - 8:58 AM | DEBATE: Hybrid Endo-Open Surgery Is The Ideal Treatment For Nutcracker Syndrome |
Presenter(s):Manju Kalra, MBBS | |
View Slides in PDF | |
8:59 AM - 9:04 AM | Panel Discussion |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
|
|
x | |
9:05 AM - 9:10 AM | Exactly What Is The Tissue Causing Post-Thrombotic Venous Obstruction |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
9:11 AM - 9:16 AM | DEBATE: Open Excisional Surgery For Post-Thrombotic Common Femoral Vein Obstruction (Endophlebectomy) Is Of Limited Value In the Endovascular Era |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
9:17 AM - 9:22 AM | DEBATE: Open Excisional Surgery For Post-Thrombotic Common Femoral Vein Obstruction (Endophlebectomy) Is Standard Of Care |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
9:23 AM - 9:28 AM | Step By Step Endophlebectomy Of Common Femoral Vein |
Presenter(s):Marzia Lugli, MD | |
View Slides in PDF | |
9:29 AM - 9:34 AM | Surgical Reconstruction Of Deep Veins: Do I Do It To Improve Inflow Of Obstructive Disease Or To Control Reflux |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
STENTS AND STENT TRIALS | |
9:35 AM - 9:40 AM | Engineering Challenges Required For An Ideal Ilio-Caval Stent |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
9:41 AM - 9:46 AM | Dedicated Venous Stents Make Sense |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | Results With Dedicated Venous Self-Expanding Oblique Hybrid Nitinol Stent |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Vernacular (Venovo) Stent Trial And Methodology |
Presenter(s):Michael D. Dake, MD | |
View Slides in PDF | |
9:59 AM - 10:04 AM | An Update On VIVO-EU: The Zilver Vena Venous Stent Study In Europe |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
10:05 AM - 10:10 AM | VIRTUS - 12-Month Results: VICI Venous Stent – Feasibility Study |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
10:11 AM - 10:16 AM | The Modena Iliac Vein Stent Experience |
Presenter(s):Marzia Lugli, MD | |
View Slides in PDF | |
OFF-LABEL STENT USE | |
10:17 AM - 10:22 AM | Crossing Femoro-Iliocaval Chronic Total Occlusions: From Soft Wires To Sharp Harpoons |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
10:23 AM - 10:28 AM | DEBATE: Femoral Vein Stenting Succeeds Under These Conditions |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
10:29 AM - 10:34 AM | DEBATE: Femoral Vein Stenting Fails Often And Early |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
10:35 AM - 10:40 AM | DEBATE: Femoral Vein Angioplasty (Not Stents): Must Look And Treat Popliteal Vein And Below To Succeed Often |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
10:41 AM - 10:46 AM | Panel Discussion |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION; WOUNDS AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
Moderators:Marc A. Passman, MD / Joseph D. Raffetto, MD
|
|
x | |
10:47 AM - 10:52 AM | Years Of Planning Venous Stents: What I Have Learned |
Presenter(s):Olivier Hartung, MD | |
View Slides in PDF | |
10:53 AM - 10:58 AM | Z-Stent Extension Into The Cava: Reduces Contralateral Iliac Vein Thrombosis: Short Term Data |
Presenter(s):Erin H. Murphy, MD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | Step By Step Deep Venous Valve Repair Or Creation |
Presenter(s):Marzia Lugli, MD / Oscar Maleti, MD | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Deep Venous Reflux Reconstruction Techniques |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
11:11 AM - 11:16 AM | Deep Venous Obstruction Reconstructive Techniques |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
WOUNDS AND NEW HORIZONS | |
11:17 AM - 11:22 AM | Venous Ulcer: Clinical Evaluation Wound Care, Compression, Surgical Treatment, Ancillary Measures |
Presenter(s):Marc A. Passman, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | RCT Demonstrating Benefits Of Sulodexide For Venous Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | Important RCTs For Venous Wound Healing |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | Surgical Intervention On Venous Ulcer Based On Cost-Effectiveness: Is It Different Than C2 |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Proteomics And Degradomics In Venous Leg Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Slides in PDF | |
11:47 AM - 11:52 AM | Not All Leg Ulcers Are Venous |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
11:53 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM INCLUDING THE AXILLO SUBCLAVIAN SYSTEM
Moderators:Joann Lohr, MD / Gregory L. Moneta, MD
|
|
x | |
VENOUS THROMBOEMBOLISM (VTE) MEDICAL | |
1:00 PM - 1:05 PM | Experimental Insights Into Acute DVT And Post-Thrombotic Syndrome (PTS) |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Calf Muscle Compartment Pressure In Acute Iliofemoral DVT And The Effect Of Early Thrombus Removal |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Update On Reversal Agents For The Direct Oral Anticoagulants (DOACs) |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Isolated Soleal And Gastrocnemius Vein Thrombosis |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Popliteal Venous Entrapment: When And What Do You Do |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Biomarkers Of Venous Thromboembolism: Do They Have A Current Role |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | What Is The True Incidence Of PE In Patients With Ilio-Femoral DVT: How Many Of These Have Right Ventricular Strain |
Presenter(s):Divya Sridhar, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | Which DOAC For Which DVT: Can We Stratify Yet |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
1:48 PM - 1:54 PM | Panel Discussion |
VTE-INTERVENTIONAL | |
Moderator(s): Brian G. DeRubertis, MD / Suresh Vedantham, MD | |
1:55 PM - 2:00 PM | Technical Considerations And Emerging Technology For Chronic Venous Occlusions |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
2:01 PM - 2:06 PM | What Is The Best Method To Measure Venous Thrombolysis Resolution |
Presenter(s):Akhilesh K. Sista, MD | |
View Slides in PDF | |
2:07 PM - 2:12 PM | If The ATTRACT Trial Is Positive What Will Happen In US/Europe/Asia |
Presenter(s):Suresh Vedantham, MD | |
View Slides in PDF | |
2:13 PM - 2:18 PM | Prevention Of PTS: Is The Jury Still Out: Statins And VTE |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Slides in PDF | |
2:19 PM - 2:23 PM | D-Dimer And/Or Duplex Findings To Manage DVT |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Impact Of Caval Occlusion On The Outcomes Of Thrombolysis For Iliofemoral DVT |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Vacuum-Assisted Venous Thrombectomy: Where, When, And How |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
2:36 PM - 2:41 PM | An Algorithm For The Treatment Of Paget-Schroetter’s Syndrome |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | QOL After Deep Venous Recanalization Procedures: Any Relation To Patency |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting |
Presenter(s):Enrique Criado, MD, FACS | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Evolution Of Venous In-Stent Stenosis: Do Anti-Platelet Agents Help Mitigate |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Treating Venous Thromboembolism Without Lytic Medications |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | Panel Discussion |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
|
|
x | |
MORE FEMORAL-ILIOCAVAL FLOW ISSUES | |
3:12 PM - 3:17 PM | IVC Agenesis – Is This A Real Entity |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | IVC Occlusion – Where To Reroute |
Presenter(s):Mark G. Davies, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | Benign And Malignant Caval Tumors |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Thrombosed IVC Filter: How To Recanalize The Cava And Manage The Filter |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT | |
View Slides in PDF | |
3:36 PM - 3:41 PM | IVC Replacement For Malignancy: How To Do It |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Conduit Choices For In-Line Caval Reconstruction |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
3:48 PM - 3:53 PM | Robotic Vena Cava Surgery |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
3:54 PM - 3:59 PM | Panel Discussion |
CAVAL INTERRUPTION | |
Moderator(s): John E. Rectenwald, MD, MS / David L. Gillespie, MD | |
4:00 PM - 4:05 PM | Indications For IVC Filters: Are They Being Observed |
Presenter(s):John E. Rectenwald, MD, MS | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter |
Presenter(s):David Rosenthal, MD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | IVC Filter Retrieval Rates: The Influence Of Filter Design, Practice Administration And The Operator |
Presenter(s):David L. Gillespie, MD | |
View Slides in PDF | |
4:18 PM - 4:23 PM | The PREPIC Trial: Fact Or Fiction |
Presenter(s):John E. Rectenwald, MD, MS | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Update On The PRESERVE Vena Cava Filter Study |
Presenter(s):David L. Gillespie, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | Ulcer Healing And Quality Of Life Outcomes After Endovascular Iliocaval Reconstruction (Stenting) In Patients With Concomitant IVC And Iliac Occlusive Disease |
Presenter(s):Steven D. Abramowitz, MD / Edward Y. Woo, MD | |
View Slides in PDF | |
4:36 PM - 4:41 PM | Major Complications After IVC Filter Placement And How To Avoid Them |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
4:42 PM - 4:47 PM | Difficult Caval Filter Retrieval: Tips And Tools |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
4:48 PM - 4:53 PM | What To Do With Fractured Filters And Embolic Filter Fragments |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
4:54 PM - 5:00 PM | Which Bariatric Surgery Patients Benefit From Prophylactic Caval Filtration |
Presenter(s):Nicholas J. Gargiulo III, MD, RVT, RPVI, RDMS, FACS | |
View Slides in PDF | |
5:01 PM - 5:12 PM | Panel Discussion End of Program L |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
INTRODUCTION TO VASCULAR MALFORMATIONS
Moderators:Krassi Ivancev, MD, PhD / Furuzan Numan, MD
|
|
x | |
6:45 AM - 6:50 AM | Welcome |
Presenter(s):Krassi Ivancev, MD, PhD | |
6:50 AM - 7:00 AM | The ISSVA Vascular Anomalies Classification System |
Presenter(s):Leo J. Schultze Kool, MD, PhD | |
View Slides in PDF | |
7:00 AM - 7:10 AM | MR Imaging And MR Guided Treatment Techniques Of Congenital Vascular Malformations |
Presenter(s):R. Sean Pakbaz, MD | |
7:10 AM - 7:20 AM | Techniques And Considerations For Endovascular Access And Embolization Procedures In A Specialized Population: Neonates And Children |
Presenter(s):James Donaldson, MD | |
View Slides in PDF | |
7:20 AM - 7:30 AM | The Yakes AVM Classification System And Its Therapeutic Implications In Challenging Cases |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
HIGH FLOW VASCULAR MALFORMATION MANAGEMENT STRATEGIES
|
|
x | |
7:30 AM - 7:40 AM | Tips And Tricks For nBCA AVM Embolization: Long-Term Patient Outcomes And Complications: The Lenox Hill Heart & Vascular Institute of New York Experience |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
7:40 AM - 7:50 AM | Extracranial To Intracranial Dangerous Arterial Anastomoses: Important Considerations In Endovascular Management Of Head & Neck AVMs |
Presenter(s):R. Sean Pakbaz, MD | |
7:50 AM - 8:00 AM | nBCA And Ethanol Endovascular Techniques Used For Complex AVM Treatment Strategies: The San Diego Vascular Malformation Experience |
Presenter(s):R. Sean Pakbaz, MD | |
8:00 AM - 8:10 AM | Tips And Tricks Of Complex Peripheral AVM Endovascular Treatment With Onyx: The University of Istanbul Medical Center Experience |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
8:10 AM - 8:20 AM | Onyx AVM Embolotherapy: Detailed Histologic Evaluation Of Post-Op Resected Specimens: The University of Arkansas at Little Rock Experience |
Presenter(s):Mollie Meek, MD | |
View Slides in PDF | |
8:20 AM - 8:30 AM | Odyssey From Onyx To Ethanol In AVM Endovascular Treatment: The University of Warsaw Medical Center Experience |
Presenter(s):Mikolaj Wojtaszek, MD, PhD | |
View Slides in PDF | |
8:30 AM - 8:40 AM | Use Of A New AVM Classification System To Treat High-Flow Vascular Malformations At The University of Olomouc Medical Center: The Czech Experience |
Presenter(s):Martin Koecher, MD | |
View Slides in PDF | |
8:40 AM - 8:50 AM | Salvage Endovascular Procedures For Onyx AVM Treatment Failures: A Worldwide Experience |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
DEBATE: PALLIATIVE POLYMERIZING AGENTS VS. CURATIVE ETHANOL/COILS APPROACHES: WHICH IS BEST | |
8:50 AM - 8:55 AM | The Best Management For AVMs Is Done With Polymerizing Agents (NBCA, Onyx) |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
8:55 AM - 9:00 AM | The Best Management For AVMs Is Done With Polymerizing Agents (NBCA, Onyx) |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
9:00 AM - 9:05 AM | The Best Management For AVMs Is Done With Ethanol, And In Yakes Type I/IIIa/IIIb AVMs With Coils/Ethanol |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
9:05 AM - 9:10 AM | The Best Management For AVMs With Ethanol And/Or Coils By SMC Classification |
Presenter(s):Young Soo Do, MD, PhD | |
View Slides in PDF | |
9:10 AM - 9:20 AM | Audience Questions For The Panel |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
LOW FLOW VASCULAR MALFORMATION MANAGEMENT
|
|
x | |
9:20 AM - 9:30 AM | Use Of Sotradecol, Foam, And Other Sclerosants: Long-Term Follow-Up And Complications In A Pediatric Population: The Ann & Robert H. Lurie Children’s Hospital Experience In Chicago |
Presenter(s):James Donaldson, MD | |
View Slides in PDF | |
9:30 AM - 9:40 AM | Comparative Use Of Bleomycin And Ethanol In Low-Flow Vascular Malformations Treatment In Multiple Anatomies At The Ninth People’s Hospital: The Shanghai Experience |
Presenter(s):Xindong Fan, MD | |
View Slides in PDF | |
9:40 AM - 9:50 AM | Techniques And Sclerosants For Venous And Lymphatic Malformation Treatment At The St. Radboud University Medical Center: The Dutch Experience |
Presenter(s):Leo J. Schultze Kool, MD, PhD | |
View Slides in PDF | |
9:50 AM - 10:00 AM | The Interventional Radiologist’s Role In The Klippel-Trenaunay & Parkes – Weber Syndromes And Other Tissue Overgrowth Disorders: The Emory University Medical Center Experience In Atlanta |
Presenter(s):Louis G. Martin, MD | |
View Slides in PDF | |
10:00 AM - 10:10 AM | Complex Low-Flow Vascular Malformations And The Journal Reports Of Multiple Sclerosant Agents: A World In Endovascular Confusion And Chaos |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
10:10 AM - 10:30 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
SURGERY IN VASCULAR MALFORMATION MANAGEMENT
Moderators:Jia Wei Zheng, PhD / Dong-ik Kim, MD
|
|
x | |
10:30 AM - 10:40 AM | Surgical Approaches To Vascular Malformation Management: Triumphs And Pitfalls |
Presenter(s):Christopher J. Morin , MD | |
View Slides in PDF | |
10:40 AM - 10:50 AM | Combined Endovascular And Surgical Management Strategies In Complex Vascular Malformation Treatment At The Samsung Medical Center: The Seoul Experience |
Presenter(s):Dong-ik Kim, MD | |
View Slides in PDF | |
10:50 AM - 11:00 AM | Reconstructive Surgical Issues With Complex Vascular Malformations |
Presenter(s):Tanya M. Oswald, MD | |
View Slides in PDF | |
11:00 AM - 11:10 AM | Surgical Strategies For Lymphatic Malformations At The Ninth People’s Hospital: The Shanghai Experience |
Presenter(s):Jia Wei Zheng, PhD | |
11:10 AM - 11:20 AM | Surgical Reconstructions And Patient Normalization Post-Endovascular Ablation Of Head & Neck Vascular Malformations |
Presenter(s):Randolph C. Robinson, MD, DDS | |
View Slides in PDF | |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
AVM COMPLICATIONS WE ALL ENCOUNTER - IF YOU ARE DOING AVM CASES, THESE WILL OCCUR - LET US LEARN TOGETHER FOR OUR PATIENTS’ SAKE
Moderators:Robert J. Rosen, MD / Louis G. Martin, MD
|
|
x | |
11:20 AM - 11:25 AM | AVM Complications Case Presentation |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
11:25 AM - 11:30 AM | AVM Complications Case Presentation |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
11:30 AM - 11:35 AM | AVM Complications Case Presentation |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | AVM Complications Case Presentation |
Presenter(s):Louis G. Martin, MD | |
View Slides in PDF | |
END OF SESSION 96 | |
SESSION 97 SCHEDULE | |
Friday
SESSION 97:
HOW DO I DO THESE CASES RIGHT
Moderators:Young Soo Do, MD, PhD / Iris Baumgartner, MD
|
|
x | |
11:40 AM - 11:45 AM | How Do I Determine Where The Damn Nidus Is |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
11:45 AM - 11:50 AM | Upper Extremity And Hand AVMs: How I Do It |
Presenter(s):Young Soo Do, MD, PhD | |
View Slides in PDF | |
11:50 AM - 11:55 AM | How I Treat Plantar Foot AVMs |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
11:55 AM - 12:00 PM | How I Treat Pelvic AVMs |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
12:00 PM - 12:10 PM | How I Treat Problematic Intraosseous AVMs |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
12:10 PM - 12:20 PM | Pick Up Lunch in the South Corridor Exhibit Area (2nd Floor) and Return to the Gramercy Suites for Luncheon Program. |
END OF SESSION 97 | |
SESSION 98 SCHEDULE | |
Friday
SESSION 98:
COMPLEX AVMs THAT PURPOSEFULLY CONFOUND US
|
|
x | |
12:20 PM - 12:30 PM | Curative Endovascular AVM Treatment Techniques Utilizing The Retrograde Vein Approach: The Northwestern Memorial Hospital Experience In Chicago |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
12:30 PM - 12:40 PM | Complex AVM Curative Endovascular Treatment At The Samsung Medical Center: The Korean Experience |
Presenter(s):Young Soo Do, MD, PhD | |
View Slides in PDF | |
12:40 PM - 12:50 PM | The Vascular Malformation International Road Show At The International Medical Center In Cairo And At The Medical University Hospital Of Lubin, Poland |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
12:50 PM - 1:00 PM | Curative Treatment Of Challenging Scalp, Ear And Mandible AVMs At The Ninth People’s Hospital: The Shanghai Experience |
Presenter(s):Xindong Fan, MD | |
View Slides in PDF | |
1:00 PM - 1:10 PM | Complex AVM Endovascular Management Techniques: The University of Arkansas at Little Rock Experience |
Presenter(s):Mollie Meek, MD | |
View Slides in PDF | |
1:10 PM - 1:20 PM | Endovascular Curative Treatment Strategies Of patients With Multiple Complex AVMs: The Denver Experience |
Presenter(s):Wayne F. Yakes, MD | |
View Slides in PDF | |
1:20 PM - 1:30 PM | Panel Discussion (All AVM Faculty) End of Program M |
END OF SESSION 98 |